Zynex Medical (ZYXI): Kapitalisasi marang pendapatan

Zynex, Inc. (ZYXI) is scaling sales of home electrostimulation, offering a safe alternative to opioids through an extensive physician network. The divergence of the P/S ratio from its historical average reflects the dynamics of the business's market valuation, where the current parameter is 0.00. Growth is constrained by the complexity of insurance reimbursements and stringent FDA requirements, which create significant barriers to entry for competitors in the pain therapy segment.

Zynex, Inc. (ZYXI) is strengthening its market position by diversifying medical systems for home and inpatient pain management. The P/S multiple compares the business's market value to its annual revenue, determining the cost of one dollar of sales. Investors utilize this balance to assess whether the asset is overbought and to analyze the liquidity of large positions. This price action is clearly reflected through the historical P/S value of Zynex, Inc. (ZYXI).